An oBservational retrospective Analysis of treatment patternS and Effectiveness of standard of CAre for Multiple Myeloma Patients Exposed to Lenalidomide and a Proteasome Inhibitor: BasecaMMp Study
These findings highlight the lack of a clear standard of care, poor clinical outcomes, and the need for more effective therapies and treatment strategies for this population.
Authors
- Guido Nador
- Olivia Ashman
- Moritz Lehne (ORCID: https://orcid.org/0000-0001-8435-1374)
- Paul Cislo
- Kai Strobel
- Jaime Luna
- Markus Rückert
- Keltie O’Neill
- Sebastian Theurich
- James Farrell
- K. Martin Kortüm
Institutions
- German Cancer Research Center (DE)
- Pfizer (United States) (US)
- Pfizer (United Kingdom) (GB)
- Heidelberg University (DE)
- University Medical Center Freiburg (DE)
- University Hospital Heidelberg (DE)
- LMU Klinikum (DE)
- Universitätsklinikum Würzburg (DE)
- Protestant University of Applied Sciences Freiburg (DE)
- Pfizer (Ireland) (IE)
- Ludwig-Maximilians-Universität München (DE)
- Cytel (United States) (US)
Publication Details
- Journal
- Clinical Lymphoma Myeloma & Leukemia
- Published
- 2026-02-01
- DOI
- https://doi.org/10.1016/j.clml.2026.01.013
- Citations
- 1
- Primary Topic
- Multiple Myeloma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 35.41
Funders
- Pfizer